Nalan Selcuk-Alan
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
The role of 68Ga-FAPi PET/CT in Staging and Restaging of Breast Cancer Subtypes with Limited 18F-FDG Uptake.
Journal: Molecular imaging and radionuclide therapy
Published: August 18, 2026
Benign bone lesions mimicking metastasis on 68Ga-FAPI PET/CT.
Journal: Nuklearmedizin. Nuclear medicine
Published: August 06, 2025
Initial Multicenter Experience with [161Tb]Tb-PSMA in [177Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer: Preliminary Results.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 27, 2025
The role of [⁶⁸Ga]Ga-FAP-2286 PET/CT in the evaluation of treatment response in gastrointestinal system malignancies.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 17, 2025
Cancer Integrin Imaging with [68Ga]Ga-Trivehexin PET/CT for a Patient with Breast Cancer and Neuroendocrine Neoplasm: A Case of Both (18F)FDG PET/CT and [68Ga]Ga-DOTATATE Positive but Integrin αvβ6 Negative Lesion on [68Ga]Ga-Trivehexin PET.
Journal: Molecular imaging and radionuclide therapy
Published: June 03, 2025
[177Lu]Lu-FAP-2286 therapy in ovarian neuroendocrine carcinoma: a promising theranostic approach.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 21, 2025
Improved Accuracy and Reliability of PRIMARY Scoring Using Delayed [68Ga] Ga-PSMA PET/CT Imaging.
Journal: Molecular imaging and radionuclide therapy
Published: February 07, 2025
Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings.
Journal: Molecular imaging and radionuclide therapy
Published: February 07, 2025
Revision of the Histopathological Examination Following 68Ga-DOTA-FAPI-04 PET/CT of a Breast Tumor Diagnosed as Invasive Ductal Carcinomatosis.
Journal: Molecular imaging and radionuclide therapy
Published: July 01, 2024
Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of clinical medicine
Published: June 30, 2024
Initial Findings on the Use of [225Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors.
Journal: Molecular imaging and radionuclide therapy
Published: October 23, 2023
Clinical Experience with [225Ac]Ac-PSMA Treatment in Patients with [177Lu]Lu-PSMA-Refractory Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 31, 2023
Last Updated: 09/26/2026